Michael L Parchman1, Robert B Penfold2, Brooke Ike3, David Tauben4, Michael Von Korff2, Mark Stephens5, Kari A Stephens6, Laura-Mae Baldwin3. 1. Kaiser Permanente Washington Health Research Institute, Seattle, Washington michael.x.parchman@kp.org. 2. Kaiser Permanente Washington Health Research Institute, Seattle, Washington. 3. Department of Family Medicine, University of Washington, Seattle, Washington. 4. Department of Medicine, University of Washington, Seattle, Washington. 5. Change Management Consulting, Seattle, Washington. 6. Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, Washington.
Abstract
PURPOSE: Six key elements of opioid medication management redesign in primary care have been previously identified. Here, we examine the effect of implementing these Six Building Blocks on opioid-prescribing practices. METHODS: Six rural-serving organizations with 20 clinic locations received support for 15 months during the period October 2015 to May 2017 to implement the Six Building Blocks. Patients undergoing long-term opioid therapy (LtOT) at these study sites were compared with patients undergoing LtOT enrolled in a regional health plan who did not receive care at the study sites but who resided in the same primary care service areas (control group). Outcomes were monthly trend in the proportion of patients undergoing LtOT prescribed a ≥100 morphine equivalent dose (MED) of opioids daily and the total number of patients receiving an opioid prescription. An interrupted time series using difference-indifference analysis was used for tests of significance. RESULTS: The proportion of patients prescribed a ≥100 MED of opioids daily decreased 2.2% (11.8% to 9.6%) among patients at the intervention clinics and 1.3% (14.0% to 12.7%) among patients in the control group. The rate of decrease was significantly greater among study patients than among patients in the control group (P = .018). The rate of decrease in the number of patients on LtOT at intervention clinics increased during the intervention period compared with the preintervention period (P <.001). CONCLUSIONS: Efforts to redesign opioid medication management in primary care resulted in a significant decrease in opioid prescribing. Future research is needed to determine if these results are generalizable to other settings and to assess implications for patient-reported outcomes.
PURPOSE: Six key elements of opioid medication management redesign in primary care have been previously identified. Here, we examine the effect of implementing these Six Building Blocks on opioid-prescribing practices. METHODS: Six rural-serving organizations with 20 clinic locations received support for 15 months during the period October 2015 to May 2017 to implement the Six Building Blocks. Patients undergoing long-term opioid therapy (LtOT) at these study sites were compared with patients undergoing LtOT enrolled in a regional health plan who did not receive care at the study sites but who resided in the same primary care service areas (control group). Outcomes were monthly trend in the proportion of patients undergoing LtOT prescribed a ≥100 morphine equivalent dose (MED) of opioids daily and the total number of patients receiving an opioid prescription. An interrupted time series using difference-indifference analysis was used for tests of significance. RESULTS: The proportion of patients prescribed a ≥100 MED of opioids daily decreased 2.2% (11.8% to 9.6%) among patients at the intervention clinics and 1.3% (14.0% to 12.7%) among patients in the control group. The rate of decrease was significantly greater among study patients than among patients in the control group (P = .018). The rate of decrease in the number of patients on LtOT at intervention clinics increased during the intervention period compared with the preintervention period (P <.001). CONCLUSIONS: Efforts to redesign opioid medication management in primary care resulted in a significant decrease in opioid prescribing. Future research is needed to determine if these results are generalizable to other settings and to assess implications for patient-reported outcomes.
Authors: Jane M Liebschutz; Ziming Xuan; Christopher W Shanahan; Marc LaRochelle; Julia Keosaian; Donna Beers; George Guara; Kristen O'Connor; Daniel P Alford; Victoria Parker; Roger D Weiss; Jeffrey H Samet; Julie Crosson; Phoebe A Cushman; Karen E Lasser Journal: JAMA Intern Med Date: 2017-09-01 Impact factor: 21.873
Authors: Michael Von Korff; Sascha Dublin; Rod L Walker; Michael Parchman; Susan M Shortreed; Ryan N Hansen; Kathleen Saunders Journal: J Pain Date: 2015-10-22 Impact factor: 5.820
Authors: Michael L Parchman; Michael Von Korff; Laura-Mae Baldwin; Mark Stephens; Brooke Ike; DeAnn Cromp; Clarissa Hsu; Ed H Wagner Journal: J Am Board Fam Med Date: 2017-01-02 Impact factor: 2.657
Authors: Erin E Krebs; Amy Gravely; Sean Nugent; Agnes C Jensen; Beth DeRonne; Elizabeth S Goldsmith; Kurt Kroenke; Matthew J Bair; Siamak Noorbaloochi Journal: JAMA Date: 2018-03-06 Impact factor: 56.272
Authors: JoAnn E Kirchner; Mona J Ritchie; Jeffery A Pitcock; Louise E Parker; Geoffrey M Curran; John C Fortney Journal: J Gen Intern Med Date: 2014-12 Impact factor: 5.128
Authors: Joseph W Frank; Travis I Lovejoy; William C Becker; Benjamin J Morasco; Christopher J Koenig; Lilian Hoffecker; Hannah R Dischinger; Steven K Dobscha; Erin E Krebs Journal: Ann Intern Med Date: 2017-07-11 Impact factor: 25.391
Authors: Andrew Quanbeck; Randall T Brown; Aleksandra E Zgierska; Nora Jacobson; James M Robinson; Roberta A Johnson; Brienna M Deyo; Lynn Madden; Wen-Jan Tuan; Esra Alagoz Journal: Implement Sci Date: 2018-01-25 Impact factor: 7.327
Authors: Kari A Stephens; Brooke Ike; Laura-Mae Baldwin; Christine Packer; Michael Parchman Journal: J Am Board Fam Med Date: 2021 Jan-Feb Impact factor: 2.657
Authors: Benjamin J Morasco; Melissa H Adams; Elizabeth R Hooker; Patricia E Maloy; Erin E Krebs; Travis I Lovejoy; Somnath Saha; Steven K Dobscha Journal: J Gen Intern Med Date: 2022-03-16 Impact factor: 5.128
Authors: Edward Kwon; Christopher Stange; Katy Reichlin; Hamilton Vernon; Akira Miyanari; Elizabeth Bier; Hind Beydoun; Virginia Kalish Journal: Perm J Date: 2021-10-29
Authors: Brooke Ike; Laura-Mae Baldwin; Sarah Sutton; Nicole Van Borkulo; Christine Packer; Michael L Parchman Journal: J Am Board Fam Med Date: 2019 Sep-Oct Impact factor: 2.657
Authors: Anna R Morgan; Michelle A Hendricks; Sanae El Ibrahimi; Sara E Hallvik; Brigit Hatch; Caitlin Dickinson; Dagan Wright; Michael A Fischer Journal: Drugs Context Date: 2021-12-15
Authors: Kari A Stephens; Imara I West; Kevin A Hallgren; Brenda Mollis; Kris Ma; Dennis M Donovan; Brenda Stuvek; Laura-Mae Baldwin Journal: J Subst Abuse Treat Date: 2020-03
Authors: Michael L Parchman; Brooke Ike; Katherine P Osterhage; Laura-Mae Baldwin; Kari A Stephens; Sarah Sutton Journal: J Clin Transl Sci Date: 2020-01-10